Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Immune Pharmaceuticals completes private placement of convertible notes

November 18, 2016 9:20 PM UTC

Immune Pharmaceuticals raised $1 million in a convertible note from an existing investor. The company may raise up to an additional $10 million from the investor....

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Immune Pharmaceuticals Inc.